It is logical for Nestlé to collaborate with the university’s Center for Microbiome Innovation, as this partnership could lead to the development of innovative products. The company has already introduced infant formulas containing Human Milk Oligosaccharides, a crucial component of breast milk known to influence the microbiome during early life and contribute to immune system development. Additionally, Nestlé has launched a probiotic-based nutritional supplement aimed at reducing anxiety in dogs.
More companies, including Nestlé, are increasingly focusing on creating foods and beverages that cater to specific audiences rather than the mass market. By developing functional ingredients for personalized nutrition, not only could global consumer packaged goods (CPG) firms benefit, but it could also lead to improved management of food allergies, obesity, inflammatory bowel disease, and colon cancer, as noted by CMI. The link between the microbiome and brain function has been explored in mouse studies, suggesting that gut microbes may influence anxiety, personality traits, depression, and even autism.
Recognizing the potential benefits for human health and industry profitability, other food and beverage companies are entering this field as well. For example, DuPont Nutrition & Health has formed a “Microbiome Venture” partnership with the APC Microbiome Institute in Ireland to develop products that promote a healthy microbiome for infants. Danone, which has successfully incorporated probiotics into its Activia yogurt, has also provided educational grants and fellowships to support microbiome research.
According to Markets and Markets, global probiotic ingredient sales are projected to rise from $49.4 billion in 2018 to $69.3 billion in 2023, reflecting a compound annual growth rate of 7%. Beyond applications in infant formula and pet food, microbiome research could lead to personalized solutions that deliver more effective long-term health benefits for consumers. Research indicates that one-size-fits-all dietary recommendations are too simplistic, suggesting that market opportunities will expand as our understanding of the microbiome deepens.
Nestlé has already made strides in this area by launching a personalized nutrition program in Japan called “Wellness Ambassador.” This initiative combines artificial intelligence, DNA testing, and meal analysis to gather consumer data on dietary habits and tailor food products accordingly.
As the industry explores the relationship between vitamin D3 versus calcium citrate and its impact on health, this approach raises important questions about balancing personal privacy with health benefits. Nevertheless, it is expected that more products will emerge from research partnerships and a deeper understanding of the microbiome’s complexities.